Piramal Pharma (PPLPHARMA.NSE) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.7
-0.07
0.57
1.2

Details

Expected EPS
1.16293697817
Actual EPS
1.20045107424
Surprise EPS
0.04
Surprise Percent
+3.23%

Description

Piramal Pharma (PPLPHARMA.NSE) has reported earnings of 1.20045107424 per share for Q2 2025.

0 Comments

Share your thoughts